Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of pyruvate, 2-oxopropanoate. [GOC:go_curators]
Pyruvate catabolic process is a fundamental metabolic pathway that plays a pivotal role in energy production in living organisms. It involves the breakdown of pyruvate, a three-carbon molecule, to generate ATP (adenosine triphosphate), the primary energy currency of cells. This process occurs in the mitochondria, the powerhouses of cells, and can be divided into three main stages:
1. **Glycolysis:** This initial stage occurs in the cytoplasm and involves the breakdown of glucose into two molecules of pyruvate. During glycolysis, two molecules of ATP and two molecules of NADH (nicotinamide adenine dinucleotide) are produced.
2. **Pyruvate oxidation:** In this stage, pyruvate is transported from the cytoplasm into the mitochondrial matrix, where it is decarboxylated (loses a carbon dioxide molecule) to form acetyl-CoA (acetyl coenzyme A). This reaction is catalyzed by the enzyme pyruvate dehydrogenase complex, which requires several coenzymes, including thiamine pyrophosphate (TPP), lipoic acid, NAD+, and Coenzyme A.
3. **Krebs cycle (also known as the citric acid cycle):** Acetyl-CoA enters the Krebs cycle, a series of eight enzymatic reactions that generate ATP, NADH, and FADH2 (flavin adenine dinucleotide). The carbon atoms from acetyl-CoA are oxidized to carbon dioxide, and the energy released is used to generate ATP and electron carriers.
The NADH and FADH2 produced in both pyruvate oxidation and the Krebs cycle carry electrons to the electron transport chain, a series of protein complexes embedded in the mitochondrial inner membrane. This chain harnesses the energy from these electrons to pump protons across the inner membrane, creating a proton gradient. The potential energy stored in this gradient is then used by ATP synthase to generate ATP via oxidative phosphorylation.
Pyruvate catabolism is a crucial pathway for energy production in all living organisms. It is essential for cellular respiration, the process that allows cells to convert nutrients into energy. Disruptions in pyruvate catabolism can lead to various metabolic disorders and diseases. For example, deficiencies in pyruvate dehydrogenase complex can result in lactic acidosis, a condition characterized by an accumulation of lactic acid in the blood.'
"
Protein | Definition | Taxonomy |
---|---|---|
Monocarboxylate transporter 1 | A monocarboxylate transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P53985] | Homo sapiens (human) |
Monocarboxylate transporter 4 | A monocarboxylate transporter 4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15427] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-ketoisovalerate | 3-methyl-2-oxobutanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 3-methyl-2-oxobutanoic acid, arising from deprotonation of the carboxy group. 3-methyl-2-oxobutanoic acid : A 2-oxo monocarboxylic acid that is the 2-oxo derivative of isovaleric acid. alpha-ketoisovalerate: RN given refers to parent cpd | 2-oxo monocarboxylic acid; branched-chain keto acid | human metabolite; Saccharomyces cerevisiae metabolite |
alpha-ketobutyric acid | 2-oxobutanoic acid : A 2-oxo monocarboxylic acid that is the 2-oxo derivative of butanoic acid. alpha-ketobutyric acid: RN given refers to parent cpd; structure | 2-oxo monocarboxylic acid; short-chain fatty acid | |
2-keto-4-methylvalerate | 4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid. 4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease. alpha-ketoisocaproic acid: RN given refers to parent cpd | 2-oxo monocarboxylic acid; branched-chain keto acid | algal metabolite; human metabolite |
acetoacetic acid | acetoacetic acid : A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent. | 3-oxo fatty acid; ketone body | metabolite |
pyruvic acid | pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis. Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed) | 2-oxo monocarboxylic acid | cofactor; fundamental metabolite |
1-methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES 3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively. | 3-isobutyl-1-methylxanthine | |
5-nitro-2-(3-phenylpropylamino)benzoic acid | 5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist | nitrobenzoic acid | |
phloretin | dihydrochalcones | antineoplastic agent; plant metabolite | |
syrosingopine | syrosingopine: was heading 1963-94; SYRINGOPINE was see SYROSINGOPINE 1977-94; use RESERPINE to search SYROSINGOPINE 1966-94 | yohimban alkaloid | |
3-chloropropionic acid | 3-chloropropionic acid: structure | ||
2-hydroxybutyric acid | 2-hydroxybutyric acid : A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals. 2-hydroxybutyric acid: RN given refers to cpd without isomeric designation hydroxybutyric acid : Any compound comprising a butyric acid core carrying at least one hydroxy substituent. | 2-hydroxy monocarboxylic acid; hydroxybutyric acid | algal metabolite; human metabolite |
d-lactic acid | (R)-lactic acid : An optically active form of lactic acid having (R)-configuration. | 2-hydroxypropanoic acid | Escherichia coli metabolite; human metabolite |
3-hydroxybutyric acid | (R)-3-hydroxybutyric acid : The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis. | 3-hydroxybutyric acid; ketone body | fungal metabolite; human metabolite; pheromone |
(S)-3-hydroxybutyric acid | (S)-3-hydroxybutyric acid : The S-enantiomer of 3-hydroxybutyric acid; a normal human metabolite, that has been found elevated in geriatric patients remitting from depression. | 3-hydroxybutyric acid | |
coumarin 343 | coumarin 343: structure in first source | 7-aminocoumarins | fluorochrome |
7-diethylaminocoumarin-3-carboxylic acid | |||
alpha-cyano-4-hydroxycinnamic acid | alpha-cyano-4-hydroxycinnamic acid : A monohydroxycinnamic acid that is 4-hydroxycinnamic acid in which the hydrogen alpha- to the carboxy group is replaced by a cyano group. It is used as a matrix in matrix-assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of peptides and oligonucleotides. | monohydroxycinnamic acid; nitrile; phenols | MALDI matrix material |
ar c155858 | AR C155858: an MCT1 inhibitor; structure in first source | ||
azd3965 | AZD3965: a monocarboxylate transporter-1 inhibitor with antineoplastic activity; structure in first source | ||
sodium lactate | sodium lactate : An organic sodium salt having lactate as the counterion. Sodium Lactate: The sodium salt of racemic or inactive lactic acid. It is a hygroscopic agent used intravenously as a systemic and urinary alkalizer. | lactate salt; organic sodium salt | food acidity regulator; food preservative |